| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |